Financials

  • Market Capitalization 1.25 B
  • Employee 592
  • Founded N/A
  • CEO Michael Castagna
  • Website www.mannkindcorp.com
  • Headquarter Delaware, United States
  • FIGI BBG000PPL3G9
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
283.5
Price to sales ratio
5.25

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2263
INBX
Inhibrx Biosciences, Inc. - Common Stock
92.17 USD-0.90%-4.49%-3.10%+14.38%1.35 B USD
2306
ARDX
Ardelyx, Inc. - Common Stock
5.14 USD-2.65%-4.10%-10.45%+11.02%1.27 B USD
2319
IMTX
Immatics N.V. - Ordinary Shares
9.23 USD-4.65%-8.61%-3.55%-10.82%1.24 B USD
2320
CRVS
Corvus Pharmaceuticals, Inc. - Common Stock
14.71 USD-6.13%-3.92%+22.48%+236.61%1.24 B USD

Frequently asked questions about MannKind Corporation - Common Stock

What is the MannKind Corporation - Common Stock stock price today?

The current price of MannKind Corporation - Common Stock (MNKD) is 4.04. Over the past 24 hours, the stock has changed by -1.22%. Follow the MNKD chart for real-time price dynamics.

What is the stock ticker of MannKind Corporation - Common Stock?

MannKind Corporation - Common Stock trades under the ticker MNKD. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is MannKind Corporation - Common Stock stock going up?

MNKD has changed by -6.70% over the last week, +8.89% over the last month, and -23.77% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was MannKind Corporation - Common Stock net income for the last quarter?

MannKind Corporation - Common Stock reported net income of -16.62 M for the last quarter. The previous quarter showed -15.95 M, which means net income changed by -4.21%.

How many employees does MannKind Corporation - Common Stock have?

As of the latest available data, MannKind Corporation - Common Stock has 592 employees. Workforce size can provide additional context about the company's scale and operations.

What is MannKind Corporation - Common Stock EBITDA?

MannKind Corporation - Common Stock EBITDA is 2.83 M, and its EBITDA margin is 3.22%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy MannKind Corporation - Common Stock stock?

You can buy MannKind Corporation - Common Stock (MNKD) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in MannKind Corporation - Common Stock stock?

Investing in MannKind Corporation - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MNKD chart and related analysis on metatrader.com as part of your research.

MannKind Corporation - Common Stock

MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991. MannKind Corporation was named after its founder, Alfred E. Mann.

News